Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMacfarlane Grp. Regulatory News (MACF)

Share Price Information for Macfarlane Grp. (MACF)

Share Price is delayed by 15 minutes
Get Live Data
64.50    -0.30 (-0.46%)
Bid:
64.50
Ask:
65.00
Spread: 0.50 (0.775%)
Market Cap: £100.40m
MACF Live PriceLast checked at - London Stock Exchange

Intraday Macfarlane Grp. Share Chart

Interim Management Statement

16 Nov 2010 07:00

RNS Number : 2183W
Macfarlane Group PLC
16 November 2010
 



 

Interim Management Statement

 

16 November 2010

 

Macfarlane Group PLC today publishes its Interim Management Statement for the period from 30 June 2010 to date. As anticipated in the interim results announcement and in accordance with its normal trading cycle, the Group has recorded a stronger trading performance since June than in the first half of the year.

In Packaging Distribution, year to date sales levels remain 9% ahead of 2009. However following a series of industry supplier price increases in the first half of the year, further price increases have been implemented by suppliers and the inevitable delay in passing these increases on to our customer base has led to lower gross margins in the second half of 2010. As a result profits before exceptional items in this Division are currently running at similar levels to those seen in 2009.

Manufacturing Operations' sales are 9% above those seen in 2009. Having taken actions in 2009 to ensure that our cost base was aligned with lower levels of demand, both businesses in the division, Labels and Packaging Manufacturing, have traded profitably in 2010. As a result profits before exceptional items in this Division are currently ahead of those seen in 2009.

Bank borrowings have reduced since 30 June 2010 and are expected to reduce further in the remainder of 2010, as a result of traditionally strong inflows from working capital in the final months of the year.

Whilst recent rises in equity markets have improved investment values in the Group's final salary pension scheme, reductions in bond yields have offset most of this improvement. The Group remains committed to addressing the means by which the level of deficit and its volatility can be managed in future years and further actions to this effect are in progress.

Archie Hunter, Chairman of Macfarlane Group, said

"Whilst we remain cautious over future demand levels and the pass-through of supplier price increases remains a considerable challenge, we have taken actions necessary to manage the situation and the Board believes that the results for 2010 remain broadly in line with its expectations."

 

 

Further information: Archie S. Hunter Chairman 0141 333 9666

Peter D. Atkinson Chief Executive

John Love Finance Director

Callum Spreng Spreng & Co 0141 229 0482

07803 970103

 

 

 

Notes to Editors:

Macfarlane Group PLC is a UK-based group of companies focused on packaging-related activities. The Packaging Distribution business is the leading UK distributor of a comprehensive range of packaging consumable products. The Manufacturing Operations comprise two businesses, the manufacture of transit packaging and the manufacture of self-adhesive and re-sealable labels. Headquartered in Glasgow, Scotland, Macfarlane Group employs 700 people at 22 sites, principally in the UK and Ireland, servicing 20,000+ customers, in a wide range of sectors including: consumer goods; logistics; electronics; food manufacturing and retailing; internet and home retailing.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGGRGGUPUGMA
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
12th May 20263:30 pmRNSExtension of Share Buyback Programme
12th May 20263:28 pmRNSResult of AGM
12th May 20267:00 amRNSAGM Trading Update
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
6th May 20262:26 pmRNSHolding(s) in Company
5th May 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSNotice of AGM
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:40 amRNSDirector/PDMR Shareholdings
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 202612:12 pmRNSDirector/PDMR Shareholdings
2nd Mar 20268:26 amRNSHolding(s) in Company
2nd Mar 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSAnnual Results 2025
23rd Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 202611:02 amRNSHolding(s) in Company
16th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:01 amRNSNotice of Results & Investor Presentation
9th Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
22nd Dec 20258:12 amRNSTransaction in Own Shares
22nd Dec 20258:12 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTrading Update
17th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20258:27 amRNSHolding(s) in Company
10th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 202511:57 amRNSHolding(s) in Company
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.